智飞生物：重组带状疱疹ZFA01佐剂疫苗临床试验申请获受理

Core Viewpoint - The company, Zhifei Biological, has announced that its wholly-owned subsidiary, Anhui Zhifei Longkema Biological Pharmaceutical Co., Ltd., has received the clinical trial application acceptance notice for its recombinant herpes zoster vaccine ZFA01 (CHO cells) from the National Medical Products Administration [1] Group 1 - The clinical trial application acceptance number is CXSL2500978 [1] - The company can commence clinical trials within 60 days if no negative or questioning opinions are received from the drug review center after the acceptance [1]